ImmuneWalk Therapeutics
PrivateLast Round
Seed
May 7, 2025
Total Funding Raised
$7M
Company Overview
ImmuneWalk Therapeutics operates in Healthcare & Life Sciences and is based in Pearl River, New York. Its latest recorded funding round was a Seed round in May 2025.
ImmuneWalk Therapeutics is a biotechnology company that develops novel monoclonal antibody therapies for chronic inflammatory diseases by targeting monocyte migration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneWalk Therapeutics Comparables
Compare ImmuneWalk Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dren Bio | 74% | |
| Ensho Therapeutics | 74% | |
| Roche Holding | 70% |
For institutional investors. Book with your work email.
ImmuneWalk Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2025
$7M raised in Seed round.
- Sep 12, 2024
Grew 100% QoQ, from 3 to 6 employees.
For institutional investors. Book with your work email.
ImmuneWalk Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmuneWalk Therapeutics's valuation, stock price, and market status.
Is ImmuneWalk Therapeutics a public or private company?
ImmuneWalk Therapeutics is a private company.
What is the current stock price of ImmuneWalk Therapeutics?
ImmuneWalk Therapeutics is a private company, so its shares have no public market price. Caplight tracks ImmuneWalk Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmuneWalk Therapeutics worth (valuation)?
Valuation information for ImmuneWalk Therapeutics is not publicly available.
Can I buy ImmuneWalk Therapeutics stock?
ImmuneWalk Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmuneWalk Therapeutics's last funding round?
ImmuneWalk Therapeutics's most recent funding round was Seed on May 7, 2025.
Who are the main investors in ImmuneWalk Therapeutics?
Investor information for ImmuneWalk Therapeutics is not publicly disclosed.
Will ImmuneWalk Therapeutics IPO soon?
No public IPO plans have been announced for ImmuneWalk Therapeutics.
How can I track ImmuneWalk Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ImmuneWalk Therapeutics's shares on secondary markets.